Menu

Press Releases

2022-3-30-Olympic-Ophthalmics-Announces-FDA-Clearance
March 30, 2022
Olympic Ophthalmics Announces FDA Clearance and Availability of Its Next-Generation iTEAR®100 Neurostimulation Device, Expanded Patent Portfolio, and Further Clinical Studies
Read Article
2-Arctic-Vision-Announces-Exclusive-Licensing-Agreement with-Olympic-Ophthalmics-for-iTEAR®100-june6-2021
June 6, 2021
Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN Countries
Read Article
3-Olympic-Ophthalmics-Announces-Issuance-of-Two-Seminal-Patents-for-its-Neuromodulation-Technology-apr22-2021
April 22, 2021
Olympic Ophthalmics Announces Issuance of Two Seminal Patents for its Neuromodulation Technology
Read Article
4-Novel-Extranasal-Tear-Stimulation-Pivotal-Study-Results-pub-med-nov17-2020
November 17, 2020
Clinical Results: Safety and Efficacy of iTEAR®100
Read Article
2020-9-15-Dry-Eye-The-Nose-Knows
September 15, 2020
Dry Eye: The Nose Knows
Learn how neurostimulation is becoming a viable treatment option for patients who have exhausted their options.
Read Article
Olympic-Ophthalmics-Presents-Clinical-Evidence-for-iTEAR100
May 22, 2020
Olympic Ophthalmics Presents Clinical Evidence for iTEAR®100
Read Article
May 14, 2020
Olympic Ophthalmics Receives FDA Clearance for iTEAR®100 Neurostimulator
Read Article
2019-6-15-Dry-Eye-Therapy-Getting-Nosy
June 15, 2019
Dry Eye Therapy: Getting Nosy
Understand the science behind nasal stimulation.
Read Article
5-Rendia-resources-insights-new-neurostimulation-device-june3-2020
FDA Approval of iTEAR®100: An electromechanical nerve stimulator that is used externally on the nose and increases tear production
Read Article

Ready to try iTEAR®100?

Want iTEAR®100 when it returns?

Notify Me

More questions?

FAQs